Schuetz Thomas J.

Chief Executive Officer | CEO | President +2 more

1 company

Strong

Trades Analyzed

12M Win Rate

54.5%

Avg 3M Return

+25.3%

Avg 12M Return

-3.6%

Schuetz Thomas J. is a Chief Executive Officer at Compass Therapeutics, Inc.. Recent SEC Form 4 filings include 10 buys and 0 sells.

Estimated insider holdings value: $13.3M based on current market prices.

Holdings by Company

CMPXFeb 8, 2026

Current Shares6.60M

Value$13.34M

Net Activity+503.8K

Bought: 503.8KSold: 0

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 17, 2022	CMPX Compass Therapeutics, Inc.	Chief Executive Officer	Buy	15,000	$3.05	$45,750.00	+0.3%	+58.3%	-20.7%
Aug 10, 2022	CMPX Compass Therapeutics, Inc.	Chief Executive Officer	Buy	15,000	$2.64	$39,600.00	+0.3%	+58.6%	-4.1%
Aug 1, 2022	CMPX Compass Therapeutics, Inc.	Chief Executive Officer	Buy	15,000	$2.58	$38,700.00	+0.3%	+19.7%	+1.5%
Jun 21, 2022	CMPX Compass Therapeutics, Inc.	Chief Executive Officer	Buy	20,000	$2.80	$56,000.00	+0.4%	+2.4%	+16.4%
Jun 16, 2022	CMPX Compass Therapeutics, Inc.	Chief Executive Officer	Buy	20,000	$2.34	$46,800.00	+0.4%	+36.4%	+25.1%
Jun 13, 2022	CMPX Compass Therapeutics, Inc.	Chief Executive Officer	Buy	30,000	$2.29	$68,700.00	+0.6%	+48.3%	+63.7%
Jun 6, 2022	CMPX Compass Therapeutics, Inc.	Chief Executive Officer	Buy	30,000	$2.83	$84,900.00	+0.6%	+12.3%	+12.3%
Jun 1, 2022	CMPX Compass Therapeutics, Inc.	Chief Executive Officer	Buy	20,000	$3.03	$60,600.00	+0.4%	+2.4%	+1.4%
May 26, 2022	CMPX Compass Therapeutics, Inc.	Chief Executive Officer	Buy	20,000	$3.04	$60,800.00	+0.4%	+1.7%	+1.7%
May 23, 2022	CMPX Compass Therapeutics, Inc.	Chief Executive Officer	Buy	18,355	$2.72	$49,925.60	+0.4%	+10.5%	+21.7%